Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndrome

Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause

“…Postmenopausal bone loss was then effectively prevented at the level of both the radius and the spine for the duration of the study. This agrees with the findings of other studies (14,15). Favorable effects of EV plus CPA have also been shown on lipid profile, with decreased triglycerides and total cholesterol and, most importantly, heightened levels of HDL cholesterol.…”